BioFire FilmArray for Pleural Fluid: Not Recommended by Current Guidelines
Current pleural disease guidelines do not include or recommend multiplex PCR panels like BioFire FilmArray for pleural fluid analysis, and you should follow the established standard of care: sending pleural fluid in both plain containers and blood culture bottles for conventional microbiological testing 1.
Guideline-Based Standard of Care
The 2023 British Thoracic Society guidelines provide clear, strong recommendations for pleural infection workup:
- Pleural fluid should be sent in both plain and blood culture bottle tubes in patients with suspected pleural infection (Strong recommendation—by consensus) 1
Specific Collection Protocol
When pleural infection is possible and adequate volume is available:
- Send microbiological samples in white top containers
- Inoculate 5-10 mL into aerobic and anaerobic blood culture bottles 1
If limited volume (<5-10 mL available):
- Prioritize 2-5 mL to blood culture bottles rather than plain containers 1
Why BioFire Is Not Currently Recommended
Absence from Guidelines
The most recent and authoritative pleural disease guidelines (2023 BTS, 2024 ACR) make no mention of multiplex PCR panels for pleural fluid 2, 1. This is significant—these comprehensive guidelines specifically address diagnostic testing for pleural infection but do not include this technology.
Limited Evidence Base for Pleural Fluid
While research exists on BioFire for respiratory specimens, evidence for pleural fluid is extremely limited:
Only case reports exist for pleural fluid: One 2016 case report identified S. pneumoniae from pleural fluid in a child with complicated pneumonia 3, and a 2023 pediatric case series of 17 samples showed improved detection (94% vs 25% by culture) 4
The bulk of BioFire research focuses on lower respiratory tract specimens (BAL, sputum, tracheal secretions)—not pleural fluid 5, 6, 7, 8
Critical Limitations When Applied to Pleural Fluid
Even in respiratory specimens where BioFire is better studied, significant concerns exist that would be amplified in pleural fluid:
Colonization vs. True Infection: The 2024 Basel study found that while BioFire sensitivity and specificity were high, pathogen detection did not correlate well with actual pneumonia diagnosis 7. The odds ratio for pneumonia was only 1.1 for BioFire-positive only samples, compared to 2.6 for culture-positive only samples 7. Detection of organisms like H. influenzae, S. aureus, and M. catarrhalis was high but not associated with pneumonia 7.
Clinical Relevance Unclear: The 2024 Mayo Clinic RCT showed BioFire led to faster antibiotic escalation but did not improve de-escalation of broad Gram-negative coverage—a critical antimicrobial stewardship concern 8. Despite using this advanced technology, one-third of pneumonia cases still lacked microbiologic etiology 6.
Practical Clinical Approach
For Suspected Pleural Infection
Obtain image-guided thoracentesis (strong recommendation) 1
Send adequate volume: 25-50 mL total when possible 1
Microbiological testing:
- 5-10 mL into aerobic and anaerobic blood culture bottles
- Additional fluid in plain sterile containers
- Immediate pH analysis if not frank pus (pH ≤7.2 indicates high risk, requiring chest tube if safe) 1
Additional testing: Cell count, Gram stain, biochemistry (protein, LDH, glucose)
Common Pitfalls to Avoid
- Don't use BioFire as a substitute for blood culture bottles—this is not validated or guideline-supported
- Don't assume detection equals causation—even in respiratory specimens, BioFire detects colonizers
- Don't delay standard testing to pursue unvalidated molecular methods
- Don't skip tissue sampling when indicated—for tuberculous effusions, tissue sampling for culture and sensitivity is the preferred option (strong recommendation) 1
When Molecular Testing IS Recommended
The guidelines do support specific molecular tests for pleural fluid:
- Adenosine deaminase (ADA) and/or interferon-gamma for tuberculous effusion in high-prevalence populations 1
- ADA as an exclusion test in low-prevalence populations 1
These have established diagnostic thresholds and clinical validation specifically for pleural fluid.
Bottom Line
Stick with guideline-recommended conventional culture methods using blood culture bottles for pleural fluid. BioFire FilmArray lacks validation for this specimen type, is not mentioned in current guidelines, and the concerns about distinguishing colonization from infection in respiratory specimens would be even more problematic in pleural fluid. The standard approach of blood culture bottles with conventional culture remains the evidence-based standard of care.